Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV in Perilymphatic Fluid During CI
NCT04724265Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Sensitivity and specificity of CMV PCR in perilymphatic fluid at 7 days. Status: unknown.
Beyond the preview
Go deeper on NCT04724265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724265.